Richard H. Scheller, Ph.D., Executive Vice President, Genentech Research & Early Development
Sunil Agarwal, M.D., Vice President, Head of Product Development, Inflammation
Vishva Dixit, M.D., Vice President, Physiological Chemistry
Markus Gemuend, Senior Vice President, Global Head, Procurement and Contract Manufacturing Operations
Nancy Oaks, Vice President, Hematology Sales and Marketing
Michelle Rohrer, Ph.D., Vice President, U.S. Regulatory Affairs, South San Francisco
Mary B. Sliwkowski, Ph.D., Vice President, Regulatory Chemistry Manufacturing and Controls and Information Systems
Denise Smith-Hams, Senior Vice President, Human Resources Genentech, Regional Head, Human Resources North America
Geoff Teeter, Vice President, Corporate Relations


Richard H. Scheller, Ph.D.

Richard Scheller is executive vice president, Genentech Research and Early Development. In this role he is responsible for setting strategy for Genentech's research, drug discovery and early development activities. Scheller is a member of Genentech's executive committee and the Enlarged Roche Corporate Executive Committee. He also serves as the Chairman of the Genentech Foundation's Board of Directors.

Scheller joined Genentech in 2001 as senior vice president, Research and was promoted to executive vice president, Research in September 2003.

Prior to joining Genentech, Scheller was appointed to the esteemed position of professor of Molecular and Cellular Physiology and Biological Sciences in 1993 and as an investigator with the Howard Hughes Medical Institute in 1994. Scheller received his first academic appointment to Stanford University in 1982.

Scheller's work has earned him numerous awards, including the 1997 National Academy of Sciences Award in Molecular Biology. He is a member of the Academy of Arts and Sciences and the National Academy of Sciences, and has served on numerous advisory boards, including the National Advisory Mental Health Council of the National Institutes of Health. He has published more than 200 papers in peer-reviewed scientific journals.

He received his Bachelor of Science in biochemistry at the University of Wisconsin, Madison and was awarded his doctorate in chemistry from the California Institute of Technology where he was also a postdoctoral fellow, Division of Biology. Scheller was also a postdoctoral fellow at Columbia University, College of Physicians & Surgeons.

Sunil Agarwal, M.D.

Sunil Agarwal is the Vice President and Head of Product Development for the Immunology Disease Biology Area (DBA). Sunil's experience includes over eight years of progressive roles in the biotechnology industry and seven years of clinical experience. He has worked on programs ranging from Phase I to Phase IV within the autoimmune and infectious diseases therapeutic areas.

Prior to joining Genentech in 2003 Sunil was at MedImmune, Guilford and Kosan. He was most recently Senior Director, ITGR Immunology where he managed the late stage clinical science group focused in the following areas: psoriasis, rheumatic disorders and multiple sclerosis.

Agarwal obtained his bachelor of science in Neuro-Biology at Cornell University and then earned his medical degree from Tufts University School of Medicine. He completed his residency at Children's National Medical Center, Washington, D.C. and subsequently joined the faculty at George Washington University School of Medicine as an Assistant Clinical Professor of Pediatrics.

Vishva Dixit, M.D.

Vishva Dixit is vice president of Physiological Chemistry at Genentech. In this role, he leads the Department of Physiological Chemistry's efforts in basic research to study the biochemistry of components of signaling pathways that often go awry in disease. He previously held the position of vice president, Research, Molecular Oncology, where he was responsible for overseeing Genentech's research programs focused on understanding the biology of cancer, discovering novel oncology therapeutics and moving projects into the drug development pipeline. Dixit joined Genentech in 1997 as the director of the Molecular Oncology department.

Prior to joining Genentech, Dixit joined the Department of Pathology at the University of Michigan Medical School as an assistant professor before being appointed to full professor in 1995. His laboratory published a series of groundbreaking papers in the mid-nineties that defined the molecular components of the cell death receptor pathway. Dixit was awarded the Warner-Lambert/Parke David Award in Experimental Pathology in 1996, has published more than 100 scientific articles and holds a significant number of patents. Dixit continues to teach as an adjunct professor in the Department of Pharmaceutical Chemistry at the University of California, San Francisco.

Dixit received his medical degree from the University of Nairobi in Nairobi, Kenya. Following an internship at Kenyatta National Hospital, he pursued further medical training as a resident at the Department of Laboratory Medicine at Washington University School of Medicine and as a postdoctoral fellow in the University's Department of Biological Chemistry.


Markus Gemuend

Markus Gemuend is senior vice president, global head, Procurement and Contract Manufacturing Operations. In this role, Gemuend is responsible for all procurement and contract manufacturing activities within the Roche Group's Pharma Medicines organization.

Gemuend joined Genentech in 2004 as vice president, Manufacturing Collaborations and Contract Manufacturing and was subsequently promoted to senior vice president, Biochemical Manufacturing. Prior to joining Genentech, he spent 16 years at Lonza Group, Ltd., where he served as chief executive officer from 2002 to 2004. While at Lonza, Gemuend held several other leadership roles, including senior vice president and sector head for Lonza Biologics as well as vice president for Exclusive Synthesis U.S. Gemuend joined Lonza in 1988 as legal counsel.

Gemuend holds a law degree from the University of Basel, Switzerland.

Nancy Oaks

Nancy Oaks serves is vice president, Hematology Sales and Marketing. In this role, Oaks is responsible for all aspects of Genentech's U.S. hematology business. She joined Genentech in August 2006 as the national sales director for Xolair. She then held positions of increasing responsibility in Genenetch's Managed Care and Primary Care organizations.

Prior to joining Genentech, Oaks worked at Stiefel Laboratories as vice president of sales. She was also formerly with Amgen, where she held a variety of sales, operations, and marketing research positions.

Oaks holds business degrees from the Lubin School of Business at Pace University.

Michelle Rohrer, Ph.D.

Michelle Rohrer is vice president, U.S. Regulatory Affairs for South San Francisco. In this role, Rohrer has global responsibilities for oncology and virology disease areas, and oversight of all regulatory strategies for the oncology and virology global submissions. She also manages the regulatory team supporting ophthalmology and U.S. inflammation product development, as well as the U.S. commercial regulatory group.

Rohrer joined Genentech in 1993 as a postdoctoral research fellow. Since then she's held positions of increasing responsibility in the Medical Affairs and Regulatory organizations.

Prior to joining Genentech, Rohrer was a research and teaching assistant, and a National Institutes of Health (NIH) predoctoral fellow at the University of California, Davis, where she studied the effect of obesity, diabetes and AIDS on trace element metabolism.

Rohrer received her bachelor's, master's and Ph.D. degrees from the University of California, Davis.

Mary B. Sliwkowski Ph.D.

Mary Sliwkowski is vice president, Regulatory Chemistry Manufacturing and Controls and Information Systems. In this role, she oversees the technical regulatory activities for all global development and marketed products.

Sliwkowski joined Genentech in 1985 after completing a postdoctoral fellowship at the National Institutes of Health (NIH). She went on to hold positions of increasing responsibility in a variety of organizations within the company, including Cell Culture Process Sciences, Analytical Chemistry, Quality Control, Corporate Quality and Regulatory.

Sliwkowski holds a bachelor's of science degree in Chemistry from the University of Delaware and a doctorate in Biochemistry from North Carolina State University.

Denise Smith-Hams

Denise Smith-Hams is senior vice president, Regional Head, Human Resources North America. In this role, she provides day-to-day leadership, management and oversight to Genentech's human resources organization. Smith-Hams is a member of Genentech's executive committee.

Smith-Hams joined Genentech in 2002 as interim vice president of Human Resources. Prior to joining Genentech, Smith-Hams consulted with clients such as Affeymetrix, Hewlett-Packard, and Levi Strauss & Co.

Smith-Hams past appointments include, vice president, Human Resources, Monsanto Company; director, Human Resources, The Learning Company, director, Human Resources, 3Com Corporation; and manager, Strategy Development at Hewlett Packard. Overall, she has more than twenty years of human resources management and organizational development experience in technology, life sciences and biotechnology sectors.

Smith-Hams holds a Bachelor of Arts degree from the University of California, Berkeley, and a Master's degree from Mills College.

Geoff Teeter

Geoffrey P. Teeter is vice president, Corporate Relations at Genentech. In this role, he oversees the efforts of the Corporate Relations department including public affairs, corporate communications and new media, internal communications and corporate giving.

Teeter joined Genentech in 1993 as a manager, corporate communications. During the 17 years that he has worked for the company, he has developed and implemented a number of communications initiatives and strategies that have helped strengthen Genentech's corporate reputation and supported the company's goal of being a great place to work.

Prior to joining Genentech, Teeter worked on behalf of several pharmaceutical and healthcare companies at Burson-Marsteller public relations agency in Manhattan, and as a product communications manager at CIBA-Geigy Pharmaceuticals Division.

Teeter holds a bachelor's degree in mass communication from St. Bonaventure University.